Evaluación de la erupción maculopapular

Последний просмотренный: 17 Aug 2025
Last updated: 03 Jun 2025

Резюме

Отличия

Распространенные

  • Alergia a alimentos o a fármacos
  • Picaduras o mordeduras de insectos
  • Reacción adversa medicamentosa (p. ej., a un antibiótico, anticonvulsivo o alopurinol)
  • Quimioterapia
  • Infección por enterovirus y virus ECHO
  • Quinta enfermedad (eritema infeccioso)
  • Roséola (sexta enfermedad)
  • infección por virus de Epstein-Barr (VEB) (mononucleosis infecciosa)
  • Infección por citomegalovirus (CMV)
Полная информация

Редкие

  • Reacción adversa no inmediata del medio de contraste yodado
  • Necrólisis epidérmica tóxica/síndrome de Stevens-Johnson
  • Reacción medicamentosa con eosinofilia y síntomas sistémicos
  • Eritema multiforme
  • exantema por seroconversión al VIH (también conocido como síndrome retroviral agudo)
  • Mpox
  • Sepsis
  • Infección por virus de la hepatitis B aguda
  • Infección por virus de la hepatitis C aguda
  • Rubéola (sarampión alemán)
  • Rubéola (sarampión)
  • Meningococemia
  • Escarlatina
  • Dermatitis exfoliativa estafilocócica
  • Síndrome de shock tóxico (exotoxina de Staphylococcus)
  • Fiebre maculosa de las Montañas Rocosas o fiebre maculosa mediterránea
  • Enfermedad aguda de injerto contra huésped
  • Enfermedad de Kawasaki (síndrome mucocutáneo linfonodular)
  • Enfermedad de Still de inicio en la juventud o en adultos
  • Sífilis (secundario)
  • Enfermedad del Ébola
  • Infección por el virus Zika
  • Infección por el virus de chikungunya
  • Dengue
Полная информация

Составители

Авторы

Adelaide A. Hebert, MD

Professor & Director of Pediatric Dermatology

Department of Dermatology and Pediatrics

UTHealth McGovern Medical School Houston

Houston

TX

Раскрытие информации

AAH has received research grants paid to UTHealth McGovern Medical School Houston from Pfizer, GlaxoSmithKline (GSK), Novan, Dermavant, Arcutis, and Verrica; has received honoraria from Pfizer, Verrica, and Novan; and is on data safety monitoring boards for GSK, Ortho Dermatologics, and Regeneron-Sanofi.

Yamila Goenaga, MD

Dermatology Resident

Department of Dermatology

University of Texas Health Sciences Center in Houston

Houston

TX

Раскрытие информации

YG declares that she has no competing interests.

Alexander J. Jafari, MD, MPH

Clinical Research Fellow

Department of Dermatology

UTHealth McGovern Medical School Houston

Houston

TX

Раскрытие информации

AJJ declares that he has no competing interests.

Выражение благодарностей

Dr Adelaide A. Hebert, Dr Yamila Goenaga, and Dr. Alexander Jafari would like to gratefully acknowledge Dr Quoc-Bao Nguyen, Dr Mary DarConte, Dr Mark Naftanel, and Dr Hobart W. Walling, previous contributors to this topic.

Раскрытие информации

QN, MD, MN, and HWW declare that they have no competing interests.

Рецензенты

Brian Swick, MD

Clinical Assistant Professor

University of Iowa College of Medicine

Iowa City

IA

Раскрытие информации

BS declares that he has no competing interests.

Kimberly Schulz, MD

Dermatologist

Town Square Dermatology

Coralville

IA

Раскрытие информации

KS declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Resuscitation Council UK. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. May 2021 [internet publication].Полный текст

Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-73. Аннотация

McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Полный текст  Аннотация

Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022 Dec;150(6):1333-93.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности